High performance liquid chromatographic estimation of ziprasidone in pharmaceutical dosage forms

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 1, 2010, Pages 120-122

  Prasanthi, N L ^a   Rama Rao, N ^a  

^a CHALAPATHI INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Pharmaceutical dosage forms; Reverse phase HPLC; Ziprasidone

Indexed keywords

ACETONITRILE; METHANOL; POTASSIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG; ZIPRASIDONE; ZIPSYDON;

ACCURACY; ARTICLE; CALIBRATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG MIXTURE; DRUG MONITORING; DRUG PURITY; DRUG STRUCTURE; EFFLUENT; ELUTION; EQUIPMENT; FLOW RATE; METHODOLOGY; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 77953382389     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. st ed. Pharmaceutical press (London), 2002.
2. th ed. McGraw-Hill (New York), 2001.
3. Pankaj K, Choudhary P, Development and validation of spectrophotometric method for the estimation of ziprasidone HCl, Oriental Journal of Chemistry 2006; 21:1.
4. Sudha Rani B, Seshagiri Rao JVLN, Spectrophotometric Determination of Ziprasidone in Pharmaceutical Formulations, E-Journal of Chemistry 2006; 3: 9-12.
5. Sudha Rani B, Venkata Reddy P, Estimation of Ziprasidone Hydrochloride Monohydrate in Bulk and Capsules by Reverse Phase HPLC, E-Journal of Chemistry 2006; 3: 169-172.
6. Sachse J, Härtter S, Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection, Ther Drug Monit 2005; 27: 158-62.
7. Zhang G, Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection, J Chromatogr B Analyt Technol Biomed Life Sci 2007; 856: 20-8.
8. El-Sherif ZA, Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations. Biomed Chromatogr 2004; 18:143-149.
9. Aravagiri M, Pollock B, Determination of ziprasidone in human plasma by liquid chromatography- electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients, J Chromatogr B Analyt Technol Biomed Life Sci 2007; 847:237-44.
10. Aravagiri, Marder SR, Analytical technologies in the biomedical and life sciences, Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients. Journal of chromatography 2007; 847: 2.
11. Zhang G, Bartlett MG, Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma. Rapid Commun Mass Spectrum 2007; 21: 920-8.
12. Al Dirbashi, Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma, Biomedical Chromatography 2006; 20:4.
13. Kirchherr H, Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 843: 100-113.
14. Janiszewski J, Schneider RP, Mass spectrometry method for quantification of ziprasidone in human plasma. Mass Spectrom 1997; 11: 1033.